Wednesday, August 13, 2025

 
Home Blog Page 2091

NEW CALIFORNIA FIRE ERUPTS! Studio City Now on Fire, Several Structures Engulfed (VIDEO) | The Gateway Pundit

0


Structure fire in Studio City

Eco-terrorism?

A new fire in Los Angeles erupted late Wednesday night shortly after a fire exploded in the Hollywood Hills.

Several structures are on fire in Studio City.

A spox for the LAFD told KTLA the Hollywood Hills fire and Studio City fire are not connected.

KTLA reported:

A four-story structure fire in Studio City erupted and quickly spread to nearby hillside homes on Wednesday night.

The Los Angeles Fire Department reported the fire on the 3000 block of North Sunswept Drive at 8:52 p.m., saying the residence was “well involved in fire with exposures and vegetation.”

The four-story home collapsed from the flames and the wind picked up the embers to nearby brush, according to officials.

“We did just have the winds pick up again so we are seeing some ember casting from that four-story structure,” Adam Vangerpen, a spokesperson with LAFD, told KTLA around 9:30 p.m. “Our hope is to hit it hard, and we’re trying to keep it out of the brush right now.”

Vangerpen said this fire was not connected to the Sunset Fire currently burning in the Hollywood Hills.

A massive fire broke out in the Hollywood Hills near Runyon Canyon and the “Hollywood” sign Wednesday night.

The new fire dubbed “The Sunset Fire” came out of nowhere and exploded.




This story originally appeared on TheGateWayPundit

Body found in search for missing British hikers in northern Italy believed to be Samuel Harris | World News

0


The charity that one of the British hikers missing in northern Italy works for has said it is “aware of reports the body of Sam Harris has been recovered”.

The Crystal Palace Football Club charity, Palace for Life, said it was “devastated to receive this news” and its “thoughts and deepest sympathies go out to his loved ones”.

They said no further information was available on the whereabouts of his friend Aziz Ziriat.

Image:
British hikers Aziz Ziriat (left) and Samuel Harris. Pic: PA

Italian Soccorso Alpino alpine rescuers  during the search.
Pic: Soccorso Alpino/AP
Image:
Italian Soccorso Alpino alpine rescuers during the search. Pic: Soccorso Alpino/AP

Mr Harris, 35, was hiking in the Dolomites with Mr Ziriat, 36, but the pair had not been heard from since 1 January.

Both of the men, who are from London, did not check in for their flight home on Monday.

Their last known location was near a mountain hut called Casina Dosson, close to the town of Tione Di Trento, near Riva Del Garda, on Lake Garda.

Italy’s CNSAS (The National Alpine Cliff And Cave Rescue Corps) said ground teams found Mr Harris’s body “beneath the snow, at the base of a rock face, at the foot of the southern wall of Care Alto”.

Rescue teams had been searching the area after tracking a “phone of one of the two mountaineers”, a spokesperson for the organisation said.

The spokesperson added that while the investigation into his death is ongoing, “it is possible that the climber fell from above”.

Read more:
New grooming gangs inquiry ‘possible’
Snow warning issued for UK
Athletics body charged over paralympian’s death

Searches for Mr Ziriat were suspended this afternoon due to worsening weather conditions, but would resume, the organisation said, adding that the families of both men had been informed.

Joe Stone, a university friend of Mr Ziriat, previously said the pair were “experienced hikers” who liked to go off the grid, but “alarm bells were raised” when they failed to check in for their return flight.

Before the body was found, he said friends and family were “waiting anxiously” for news in the search and that “the next few hours [would] be crucial”.



This story originally appeared on Skynews

Fluoride in drinking water? Study renews debate over impact on IQ : Shots

0


Most water systems in the U.S. have fluoride added to help protect residents’ teeth. Some research raises concerns that, at high enough levels, fluoride may be linked to lower IQs in kids.

Justin Sullivan/Getty Images


hide caption

toggle caption

Justin Sullivan/Getty Images

Most communities in the U.S. add fluoride to the tap water. It has been common practice for nearly 80 years to protect against tooth decay and cavities, and it’s considered a major achievement in public health. The Centers for Disease Control and Prevention says research shows that community water fluoridation reduces cavities by around 25%.

It has also long drawn opponents who have raised concerns about the practice, ranging from evidence-based concerns to unsubstantiated conspiracy theories. The debate heated up recently when President-elect Donald Trump picked Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy is a longtime anti-vaccine activist who has also been outspoken in opposing water fluoridation, and if he’s confirmed in the role, he could influence policy.

This week, government scientists published a paper in the medical journal JAMA Pediatrics that has added to the debate. It is the analysis behind a 300-page report released last August from the National Toxicology Program, part of the National Institutes of Health.

That report concluded with “moderate confidence” that there may be a link between high levels of fluoride exposure and lowered IQ. This could indicate possible neurodevelopmental harms to pregnant people or young children, when they are exposed to drinking water containing at least 1.5 milligrams of fluoride per liter — a level more than twice what’s recommended (0.7 mg/L) for the U.S. water supply.

Monday’s analysis digs deeper into the data behind these conclusions. It looks at a few dozen foreign studies that other researchers have conducted, mostly in China and India, and finds an association between high levels of fluoride and a small decrease in children’s IQ.

“There were not enough data to determine if 0.7 mg/L of fluoride exposure in drinking water affected children’s IQ,” Christine Flowers, director of the Office of Communication at the National Institutes of Health, wrote in an email.

While the conclusions are consistent with the August report, the timing of the paper, released weeks before Trump takes office, gives it renewed prominence. The report’s contents were given “substantial weight” in a recent federal court ruling that ordered the Environmental Protection Agency to address potential risks posed by fluoride levels.

The analysis is controversial. The paper was published alongside two editorials in JAMA Pediatrics. One, by Steven Levy, a public health dentist at the University of Iowa, questioned the analysis’s methods and disagreed with its conclusions. The other, by a trio of children’s health researchers, supported its findings.

Using this analysis — which is inconclusive at levels of fluoridation below 1.5 mg/L — to inform the debate over low levels of fluoride in drinking water feels like a stretch to fluoridation supporters like Levy.

“The major problem is that the science is not as strong as it’s presented by these authors,” he says. For instance, the study authors write in the paper’s abstract that fluoride exposure seems linked (in certain studies) with lower IQ at levels even below 1.5 mg/L, but Levy notes that the data they provide aren’t conclusive.

Also, Levy says the authors didn’t fully consider some recent research that casts doubt on the links between fluoride exposure and IQ. He says there’s sometimes a pattern in public health research in which some initial studies suggest a problem, but over time, as the problem gets better studied, “the evidence goes in a somewhat different direction.” He points out that some of the more recent fluoride studies, which he thinks are better designed, found no negative effect on IQ, and he thinks they should have been given more weight in the recent analysis.

To others, the analysis published this week makes a strong enough case out of imperfect evidence for action. “What the study does, or should do, is shift the burden of proof,” says Dr. Bruce Lanphear, a children’s health researcher at Simon Fraser University, who co-authored the other editorial, which supported the paper’s findings. “The people who are proposing fluoridation need to now prove it’s safe.”

Lanphear agrees with concerns, raised by the study authors, that the base level of fluoridation, plus the myriad other sources of fluoride in people’s lives — such as toothpaste, mouthwash, and food and drinks, including some teas, fruits, vegetables and seafoods — could be pushing fluoride to harmful levels in some vulnerable people.

“There is concern that pregnant women and children are getting fluoride from many sources … and that their total fluoride exposure is too high and may affect fetal, infant, and child neurodevelopment,” wrote the NIH’s Flowers.

And while water fluoridation does clearly prevent cavities, Lanphear says the relative benefits have declined in the past few decades since people started using fluoridated toothpaste, a point supported by a recent analysis by U.K. researchers.

“There are other ways we can protect children from developing cavities,” he says. “We could, for example, regulate sugary beverages … [or] have programs to help children learn to brush their teeth more effectively.”

It’s time to reassess the potential risks of fluoride against its benefits, Lanphear says.

Those benefits are substantial and so common that they’re taken for granted, says Levy. But “it isn’t that cavities are under control for everyone,” he says. Fluoridated water most benefits those who are poor and underserved, who might not have fluoridated toothpaste or regular access to dental care.

And while cavities can be prevented in other ways, “those alternatives are for much more costly things,” Levy says. “Even [providing] fluoride toothpaste for individuals would be 10 to 20 times more costly than water fluoridation. Using fluoride mouth rinses or going to the dentist to get fluoride treatments would be much more expensive.”

Levy would like to see more high-quality research on the topic before long-standing policies get upended. But even without more scientific clarity, the debate is likely to escalate. The Environmental Protection Agency is facing a late-January deadline, should it appeal the federal court decision ordering it to reduce fluoride risks.

And Robert F. Kennedy Jr. will soon face confirmation hearings where he may have to answer direct questions about views he has aired on fluoride in the past.



This story originally appeared on NPR

Firefighters make big gains battling Sunset fire, which forced evacuations in Hollywood

0

Los Angeles firefighters have made big gains in battling the Sunset fire, which had triggered mandatory evacuation orders in Hollywood and the Hollywood Hills late Wednesday.

“It’s a miracle that no homes burned here,” one firefighter told The Times. Hours earlier, the flames had approached the mansions that line North Curson Avenue. By 10:30 p.m., flames were barely visible on the distant hillside.

“These are really nice houses up here,” one firemen said to another as they watched a helicopter fly by to drop water. Firefighters on scene said the fire had been 50 acres at its peak, and was now down to 42.3 — in retreat.

The blaze, for a short while, raised alarms throughout Hollywood. A mandatory evacuation order was issued around 5:30 p.m. for areas north of Hollywood Boulevard and south of Mulholland Drive, and east of Laurel Canyon Boulevard and west of the 101 freeway.

The was reported at 2350 N. Solar Drive in the Hollywood Hills.

The evacuation encompassed iconic locations such as the TCL Chinese Theatre, the Hollywood Pantages Theatre, the Dolby Theatre, and Ovation Hollywood, the shopping center in Hollywood.

Earlier Wednesday, David Potts, 66, stood on his front porch just a few hundred yards from the active fire, a fire truck parked directly opposite him.

Just up the hill, the crackle of flames punctuated the low hum of engines and flowing water. Every seven minutes or so, another helicopter came by and dropped water which sprinkled over the neighborhood. He stopped to see if the water had extinguished a burning tree he could see from his perch.

His home of 11 years sits next to Runyon Canyon. Around 4:30 p.m., he saw a nearby fire on the news and stepped outside to a thick smell of smoke. He could see the flames just a few hundred yards up the hill, with one property between him and the blaze.

When the mandatory evacuation notice came shortly thereafter, his wife, daughter and son-in-law quickly packed and left.

It took them two hours amid the chaos to drive to Glendale, but David stayed and got out his hose.

“A friend lost his house this morning in Altadena and I figured I would stay until the last minute,” he said.

He packed up his truck with essentials and started spraying his house and yard.

For a while, no help arrived. “Right as I was about to throw in the towel, two helicopters came,” he said. They dropped water and he saw a white cloud of steam which sent embers flying everywhere.

He kept hosing: “I could see progress from the helicopters.”

Potts knows his neighbors well, he said, and all left except for him. It fell to him to text them updates while he scrambled to find a mask, get his ladder and continuously spray everything he could reach.

Later on Wednesday, at the base of Curson Avenue — a snaking street that climbs from Franklin Boulevard into the hills adjacent to Runyon Canyon — some 50 people stood at the police line, some wearing masks and most wielding smartphones to capture the firefight. At one point, the hillside was lightly glowing.

Firefighters and residents alike credited the efficient water dropping for stemming the blaze. The nearby Hollywood reservoir allowed for frequent trips, a firefighter said. By 10:30 p.m., the water drops were happening around every ten minutes. A Times reporter could feel the drizzle of water from the water drops as the last remnants of fire could be seen from his location.

Up the hill, some firefighters stood watch as others walked hundreds of yards above with chainsaws and garden tools, cutting a fire line near the peak of Runyon Canyon. Their flashlights swung left to right as around a dozen men walked single file across the hilltop.

Most of the mandatory evacuation area was lifted except for a few city blocks, affecting areas north of Franklin Avenue, west of Camino Palmero Street and east of Sierra Bonita Avenue. Firefighters wanted the area to stay under evacuation orders to ensure vegetation in the area does not flare up.



This story originally appeared on LA Times

‘Slow Horses’ and ‘Shrinking’ nominated for acting awards

0


Gary Oldman in “Slow Horses” — image credit: Apple TV+

The Screen Actors Guild has announced its award nominations for 2025, with Apple TV+ getting most of its nods for the thriller “Slow Horses,” and the comedy “Shrinking.”

In 2024, Apple TV+ scored 11 SAG-AFTRA nominations, led chiefly by “Ted Lasso.” For the new 31st Screen Actors Guild Awards, it’s received four nominations, all for just two shows.

Gary Oldman is nominated as Outstanding Performance by a Male Actor in a Drama Series for his role in “Slow Horses.” He’s competing against Eddie Redmayne for Sky/Universal’s “The Day of the Jackal,” Jeff Bridges for FX’s “The Old Man,” and both Tadanobu Asano and Hiroyuki Sanada for “Shogun.”

Meanwhile, Harrison Ford is nominated as Outstanding Performance by a Male Actor in a Comedy Series for “Shrinking.” His competition includes Ted Danson for Netflix’s “A Man on the Inside,” and Martin Short for Hulu’s “Only Murders in the Building.”

However, Oldman and Ford could potentially take home two awards each, as both also feature in a group nomination. “Slow Horses” is nominated in the category for “Outstanding Performance by an Ensemble in a Drama Series,” while the whole cast of “Shrinking” is up for the equivalent award for comedy series.

While Apple TV+ got these nominations in the television categories and failed to score in the film ones, SAG-AFTRA also has a category for Television Movie or Limited Series. In that, Cate Blanchett was nominated for an acting award and so was Kevin Kline, both for Apple’s “Disclaimer.”

The SAG-AFTRA nominations were planned to be announced in a live ceremony in Los Angeles. Concerns over the fires in California meant the nomination ceremony was cancelled, along with premieres of the films “Unstoppable” and “Wolf Man.”

Kristen Bell will host the awards ceremony, which will be streamed live on Netflix from 8pm Eastern on February 23, 2025.



This story originally appeared on Appleinsider

Three-time UFC title challenger teases return from retirement – ‘Something BIG just happened’

0


Welcome to Midnight Mania!

Three-time UFC title challenger Chad Mendes may not be done with combat sports just yet.

“Money” was a top-ranked Featherweight contender in the World Extreme Cagefighting (WEC) and UFC for a long time. He went to absolute war with the likes of Jose Aldo and Conor McGregor in title fights, as well as taking out top names of his era like Ricardo Lamas and Cub Swanson. The heavy-handed wrestler retired from UFC competition in 2019 after a competitive loss to Alexander Volkanovski (who turned out to be pretty good), but his retirement didn’t last too long.

In 2022, Mendes returned to action under the Bare Knuckle Fighting Championship (BKFC) banner. He won his first fight via knockout then lost a split-decision to Eddie Alvarez in the BKFC 2023 “Fight of the Year” (watch highlights). After the Alvarez loss in April 2023, Mendes returned to retirement … for a time?

On Tuesday (Jan. 7, 2025), Mendes posted to social media and hinted at a return to combat sports. “The big offers keep coming in and I’m still down to whoop some ass,” he wrote. “Something BIG just happened guys…. Stay tuned.”

There are several likely options. For one, BKFC could have come to Mendes with an offer he couldn’t refuse. Alternatively, Mendes explained that he was still under UFC contract while competing in bare knuckle, so there’s a chance he could fight again inside the Octagon. Finally, Global Fight League (GFL) has been offering contracts to lots of ex-UFC contenders, so maybe Mendes inked a new deal there.

One way or another, it sounds like the 39 year old isn’t done competing just yet.

Insomnia

I’m quite curious to see how Mackenzie Dern adjusts for the Amanda Ribas rematch. She’s a lot better now than in 2019 but simultaneously has many of the same flaws.

The apparent answer to “Where does Kevin Lee fit into this?” is as a union rep.

So much for the Gilbert Burns vs. Colby Covington beef?

I appreciate Chris Curtis’ openness here.

A bit more Alex Pereira content, sparring with top-ranked Middleweight contender Caio Borralho. I feel like “Poatan” travels around and trains everywhere?

Daniel Cormier weighs in on the Jon Jones vs. Tom Aspinall UFC negotiations.

A rather cool bit of fight art that effectively shows off Islam Makhachev’s well-rounded skills.

Slips, rips, and KO clips

A lovely bit of slip-and-rip, then that first Southpaw right hook in the finishing sequence was thrown more like an overhand. Neat!

A great fight you (probably) didn’t see from 2024.

I don’t care if he’s fighting randoms, 44-year-old men shouldn’t be able to fight like this.

Random Land

Prayers and best wishes to those affected by the Palisades fires.

Midnight Music: Indie soul, 2019

Sleep well Maniacs! More martial arts madness is always on the way.




This story originally appeared on MMA Mania

Medical Tourism for Dental Implants on the Rise – Hollywood Life

0


Image Credit: Dentatur

Dental implants and other medical tourism are rising in Turkey because of increasing medical costs in Western countries. Dentatur is an Antalya dental clinic specializing in cosmetic dental work, such as implants, veneers, crowns, and other procedures. The company’s driving force is producing Hollywood-like smiles at more affordable rates. The advantages of medical tourism range from accessibility to variety, making it an option worth considering.

Many dental implants packages offer shuttles to and from the airport, making them a viable option for many patients. Turkey is a prominent destination for medical tourism because of its high-quality medical and dental treatments and affordable prices. Antalya is notable for its year-round temperate climate, well-equipped clinics, and quality medical services. Medical tourism has gained popularity in the past couple of years because it is affordable, even with travel expenses. 

Services Provided 

Dentatur’s cosmetic dental services receive high Google ratings. The positive reviews are based on the various treatments, dentist care, and modern facilities. Dental services are on par with those in Western countries but at a lower cost, which is why many patients consider traveling abroad for procedures. 

Dental Implants

Dental implants use titanium posts in the jaw that attach to the denture. This procedure permits the restoration of a complete tooth row without grinding down healthy teeth. It also eliminates the need for aggravating removable dentures. Depending on the severity of the problem, the procedure can fix single teeth or a complete set.

Veneers

Veneers are a thin yet sturdy material used on the front of damaged teeth. Their purpose is to hide cracks, chips, or blemishes in teeth. It can also conceal crooked teeth and gaps. Veneers wrap around the lower edge of the tooth so that the work is indistinguishable from the natural teeth.

Dental Crowns

Dental Crowns are a restorative treatment that covers the entire visible part of a tooth and is affixed with dental cement. The prosthetic is used to restore teeth functions, such as chewing. Crowns are made from different materials, and choosing the correct one depends on several factors that should be discussed with the dentist. 

Benefits of Dental Procedures in Turkey

Financial constraints and proper medical care are primary considerations when considering medical tourism. A significant benefit of Turkey for medical procedures is its cost-effectiveness, coupled with reputable doctors. Many clinics are technologically advanced and have high-quality clinicians and doctors. 

Turkey is also reputed to have shorter wait times for appointments. Travel opportunities are another advantage of exploring dental or medical options in Turkey, especially Antalya. As with any medical procedure, potential patients considering traveling abroad for treatment should research the destination and the specific clinic they plan to use before setting an appointment.

Medical tourism has recently increased as medical and dental procedures in Western countries are growing. Antalya, Turkey, is a popular destination for patients because of its high-quality doctors, clinics, and services. Though patients should thoroughly research the procedure before committing to it, traveling to countries like Turkey is becoming a cost-efficient solution for dental solutions. 



This story originally appeared on Hollywoodlife

2 huge investment risks I’m worried about in 2025

0


Image source: Getty Images

Investing is risky as well as rewarding, and I’ve been thinking about two investment risks that I’m worried about in particular.

2024 was a fairly good year for the UK share market with the FTSE 100 gaining nearly 6%. But now, with the year becoming a distant memory, my mind has turned to protecting my portfolio in the months ahead.

While I’m optimistic about investing in UK stocks, there’s plenty of uncertainty in the world and I’m considering buying GSK (LSE: GSK) shares as a result. But first, let’s look at those two risks.

Geopolitics

Last year was the year of elections. A big chunk of the world’s population headed to the polls including the US where Donald Trump claimed victory to secure a second term.

Analysts are watching carefully to see what policy changes the new administration will put in place. Many are tipping that deregulation could pave the way for more investment activity including mergers and acquisitions.

On the other hand, tariffs are widely expected but just how much and on which products are unclear for now. These could well stifle global and UK economic growth in 2025, despite the British government’s efforts to boost spending in key areas like housing.

Inflation pressures

Stubborn inflation is also weighing on my mind. Potential trade policy changes in the US could raise prices just as it had seemed inflation was coming under control.

Similarly, increased UK government spending could increase demand (and prices). Any large surprises may well spook investors as that could well mean the Bank of England takes a different interest rate policy path versus expectations.

Where I want to invest

These are just two investment risks that are on my mind right now and I’m looking to add more defensive exposure to my portfolio.

The Footsie boasts a number of large pharmaceutical companies, including AstraZeneca and GSK. The latter is the one that I’ve been narrowing in on in recent weeks as a potential buy.

The resiliency of the sector is certainly one part of my thinking. However, I also like that it’s a UK-based company with global footprint including strong links to the US.

Pharmaceutical companies can often pass on rising costs quite effectively to their customers, which can provide something of an inflation hedge. I also think the company’s track record as a dividend payer shows it can be investor-friendly in returning capital.

Key risks

Of course, GSK isn’t immune to risks. While the company has been actively building its research and development pipeline, there’s always uncertainty surrounding drug approvals as well as fierce competition from rivals.

Customers may also eventually reject price increases, which could hurt profitability, as could fierce competition from rivals.

Valuation

Yet the company’s 13.9 price-to-earnings (P/E) ratio is below the 14.5 average for the Footsie and looks a little cheap for a large player in a defensive industry. Rival AstraZeneca’s shares are trading at a multiple of 32, albeit it does have a £167bn market cap compared to GSK’s £56bn.

I’m certainly considering GSK shares as a way to help hedge against some of the investment risks I see looming in 2025. It’s one of the names up the top of my list to buy when I gather the funds to buy.



This story originally appeared on Motley Fool

As NATO eyes a spending surge in Trump’s second term, is it time for me to buy this FTSE defence technology gem?

0


Image source: Getty Images

FTSE 250 firm Chemring Group (LSE: CHG) looks exactly the sort of firm to me that will benefit from Donald Trump’s second presidential term. It provides advanced technology products and services to the aerospace, defence and security markets.

In his first term in office, Trump warned European NATO members that they must increase their defence spending. At that point, the target was 2% of gross domestic product (GDP). For last year, 23 of NATO’s 32 members are likely to have reached that figure.

However, according to a 20 December Financial Times report, Trump told European officials he wants this to rise to 5%.

A compelling product mix

Regardless of whether the Ukraine war ends, NATO will continue to build its defences against further Russian aggression, I think. Indeed, on 12 December NATO Secretary-General Mark Rutte said: “It is time to shift to a wartime mindset.”

In this context, Chemring designs and manufactures cutting-edge products in the Sensors & Information, and Countermeasures & Energetics sectors. These include unique systems for chemical and biological threat detection, and electronic warfare capabilities. It also produces systems for the detection of improvised explosive devices.

Aside from its big military clientele, it has civilian customers including NASA and SpaceX. It is also a leader in advanced military explosives in partnership with subsidiary Chemring Nobel.

The 2024 results

Chemring’s share price dropped 12% after the 17 December release of its 2024 results. This looked to me like an extraordinary overreaction to one negative element in otherwise excellent numbers.

Specifically, the firm’s operating margin fell to 13.9% from 14.6% in 2023. Chemring explained this was partly due to production delays at its Tennessee factory that builds infrared devices. Another part was attributable to extending a lower-margin legacy US government contract from 2016 to 2025.

Aside from that, revenue increased 8% year on year to £510.4m, and statutory operating profit jumped 28% to £58.1m.

Chemring’s order book reached an all-time high of £1.038bn, up 13% from the prior year’s £922m. Since Russia invaded Ukraine in 2022, it has jumped 59%.

A risk to its business is any major failure in a key product, which would be costly to fix and might damage its reputation.

However, analysts forecast its earnings will grow by 17.1% a year to the end of 2027. And it is increases in earnings that drive a firm’s share price and dividend.

Are the shares a bargain buy now?

discounted cash flow analysis shows Chemring shares are 63% undervalued at their current share price of £3.31.

Therefore, a fair value for the stock is technically £8.95, although market vagaries might push it lower or higher.

However, it underlines to me that the shares look an extremely good buy at this level.

Will I buy the stock?

Aged over 50 now, I focus on very-high-yielding stocks. I aim to maximise the dividends from these to continue reducing my working commitments.

Chemring currently gives a return of 2.4%, which is not in the 7%+ bracket I look for. So, it is not the right time for me to buy the shares.

That said, if I was still looking for very-high-growth potential stocks, this would be one to fit that bill.



This story originally appeared on Motley Fool

Prediction: AI stocks will outperform again in 2025 and Nvidia will hit $200

0


Artificial intelligence (AI) has been a hot investment theme for several years now. Since early 2023, AI stocks such as Nvidia (NASDAQ: NVDA), Amazon, and Alphabet have outperformed the market by a wide margin.

I’m expecting a lot of AI stocks to outperform again in 2025. And my prediction for Nvidia – which is spearheading the AI revolution – is that it will hit $200 this year.

AI is just getting started

The adoption of AI over the last two years has been incredible. ChatGPT, for example, now has around 460m visitors each month. Across the world, people are using this app to answer questions, write emails, plan trips, and much more. Here at the Fool, some of us have been having fun asking it for stock ideas (the results have been questionable).

What we’ve seen from AI so far is pretty basic, however. There’s much more to come.

In the years ahead, we’re likely to see AI go to the next level. I expect ‘AI agents’ – autonomous AI systems that can operate independently in the real world – to become a big thing. Businesses will be able to use these to automate their operations and lower costs. Meanwhile, consumers will be able to use them to plan their lives and assist with everyday tasks (scheduling appointments, booking flights, etc.).

I believe that this next phase of AI will be in focus in 2025. And I expect the share prices of companies offering genuine AI solutions (Microsoft, Amazon, Salesforce, Sage, etc.) to do well.

Nvidia at $200?

Zooming in on Nvidia, I’m targeting a share price of $200 in 2025. That would represent a gain of 43% from here.

There are several reasons I believe the stock can hit that price.

One is that Nvidia continues to roll out ground-breaking AI products. For example, earlier this week CEO Jensen Huang revealed the Cosmos world foundation model platform. This is a powerful software platform designed to advance the development of ‘physical’ AI systems such as autonomous vehicles (AVs) and robots. He also revealed a processor for AVs called Thor, solutions for agentic AI, and an AI supercomputer.

These kinds of products suggest that the company has tons of growth potential. AVs – which Huang believes will be a ‘multi-trillion dollar robotics industry’ – could be a huge revenue driver for the company, for example.

Another reason I’m targeting $200 is that the stock actually looks cheap today (despite the fact that it’s up 800%+ in two years).

For the year ending 31 January 2026 (FY2026), Nvidia’s earnings per share (EPS) are projected to rise 50% to $4.43. So, at today’s share price of $140, the forward-looking price-to-earnings (P/E) ratio is only 31.6.

That’s not high given the EPS growth. The price-to-earnings-to-growth (PEG) ratio is just 0.63 (a ratio under one suggests that a stock’s undervalued).

Now, let’s say that for FY2027, Nvidia can grow earnings by 30%. That would take EPS to $5.76. Apply a forward-looking P/E ratio of 35 to that and we have a $202 price target.

Of course, my forecasts here could be off the mark. If Big Tech companies like Microsoft stop buying Nvidia’s chips, its earnings growth could stall.

I’m very bullish on this stock, though. If it doesn’t hit $200 in 2025, I think it will hit it in the years ahead.



This story originally appeared on Motley Fool